Abbas Kazimi

Abbas Kazimi is an accomplished professional in the biotechnology and pharmaceutical sectors, currently serving as a Member of the Board of Directors at Unnatural Products Inc. since January 2025 and as the Chief Business Officer at Nimbus Therapeutics since July 2014, where responsibilities also include strategy and corporate development. Previous roles include Strategic Advisor at Pragma Bio from 2023 to 2024, and Corporate & Business Development at Extera Partners, LLC from 2010 to 2014. Abbas Kazimi gained experience in business development at JSB-Partners, LP from 2007 to 2009 and began a career in research as a Research Associate at Cambria Biosciences from 2005 to 2007, following a position as a Research Assistant at The University of Texas Health Science Center at Houston in 2002. An academic background includes a Masters in Molecular & Cellular Biology from Harvard University and a Bachelor of Arts in Asian Studies with minors in Biology and Chemistry from The University of Texas at Austin.